Announced Mon, 28 Sept, 2026 · 20:51 IST
Bliss GVS Pharma: Anupam Rasayan takes 48% control, MD resigns
Ceo ResignedKmp ResignedPromoter Family Board EntryManagement Changes View source PDFExplain this filing
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-6.6%1-day move
₹739.90
prior close
₹727.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.8-2.5-3.5-3.0-6.6-6.8-10.1-7.7-7.4-11.1————
Up moveDown movePending
AI summary
Anupam Rasayan India Ltd and PAC Mates Visa Consultancy acquired 5.09 crore shares (47.95%) of Bliss GVS Pharma, becoming new promoters per SPA dated May 23, 2026. MD S.N. Kamath resigned as part of the change in control. Three new Non-Executive Directors appointed: Hetul Mehta (pharma), Amar Shah (sales or marketing), and Pramod Kasat (investment banker). Postal ballot notice approved for shareholder approval of new directors.
Likely market impact
Major ownership change. New promoters now control 48%. Watch for strategic direction shifts and possible restructuring announcements ahead.